Tobiume M - Search Results

1

Clinical features of renal cell carcinoma less than 25 millimeters in diameter.

Yamada Y, Honda N, Mitsui K, Hibi H, Taki T, Kamijyou A, Aoki S, Abe T, Kato K, Nakamura K, Kokubo H, Naruse K, Tobiume M, Fukatsu H. Yamada Y, et al. Among authors: tobiume m. Int J Urol. 2002 Dec;9(12):663-7. doi: 10.1046/j.1442-2042.2002.00542.x. Int J Urol. 2002. PMID: 12492948 Free article.

2

Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.

Nakamura K, Yoshikawa K, Yamada Y, Saga S, Aoki S, Taki T, Tobiume M, Shimazui T, Akaza H, Honda N. Nakamura K, et al. Among authors: tobiume m. Int J Oncol. 2006 Apr;28(4):965-70. Int J Oncol. 2006. PMID: 16525647

3

Endoscope-assisted minilaparotomic radical retropubic prostatectomy.

Yamada Y, Nakamura K, Aoki S, Taki T, Kokubo H, Matsubara H, Tobiume M, Honda N. Yamada Y, et al. Among authors: tobiume m. Int J Urol. 2006 Feb;13(2):111-5. doi: 10.1111/j.1442-2042.2006.01242.x. Int J Urol. 2006. PMID: 16563133

4

Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.

Yamada Y, Naruse K, Nakamura K, Aoki S, Taki T, Tobiume M, Zennami K, Katsuda R, Inoue Y, Noguchi H, Honda N. Yamada Y, et al. Among authors: tobiume m. Oncol Rep. 2007 Jul;18(1):3-7. Oncol Rep. 2007. PMID: 17549338

5

A rare case of metastatic renal carcinoid.

Kato Y, Nakamura K, Yamada Y, Nishikawa G, Yoshizawa T, Zennnami K, Katsuda R, Tobiume M, Aoki S, Taki T, Honda N. Kato Y, et al. Among authors: tobiume m. BMC Urol. 2010 Dec 14;10:22. doi: 10.1186/1471-2490-10-22. BMC Urol. 2010. PMID: 21144059 Free PMC article.

6

Is neuroendocrine cell differentiation detected using chromogranin A from patients with bone metastatic prostate cancer a prognostic factor for outcome?

Yamada Y, Nakamura K, Aoki S, Taki T, Matsubara H, Sai S, Naruse K, Tobiume M, Katsuda R, Zennami K, Honda N, Nakagawa A, Ikeda H. Yamada Y, et al. Among authors: tobiume m. Oncol Rep. 2006 May;15(5):1309-13. Oncol Rep. 2006. PMID: 16596203

7

Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.

Aoki S, Yamada Y, Nakamura K, Taki T, Tobiume M, Honda N. Aoki S, et al. Among authors: tobiume m. Oncol Rep. 2006 Aug;16(2):279-84. Oncol Rep. 2006. PMID: 16820903

8

An immunohistochemical study of chromogranin A and human epidermal growth factor-2 expression using initial prostate biopsy specimens from patients with bone metastatic prostate cancer.

Yamada Y, Nakamura K, Aoki S, Taki T, Naruse K, Matsubara H, Tobiume M, Zennami K, Katsuda R, Honda N. Yamada Y, et al. Among authors: tobiume m. BJU Int. 2007 Jan;99(1):189-95. doi: 10.1111/j.1464-410X.2006.06500.x. Epub 2006 Oct 11. BJU Int. 2007. PMID: 17034504

9

Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis.

Naruse K, Yamada Y, Aoki S, Taki T, Nakamura K, Tobiume M, Zennami K, Katsuda R, Sai S, Nishio Y, Inoue Y, Noguchi H, Hondai N. Naruse K, et al. Among authors: tobiume m. Hinyokika Kiyo. 2007 May;53(5):287-92. Hinyokika Kiyo. 2007. PMID: 17561711 Free article.

10

Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization.

Yamada Y, Naruse K, Nakamura K, Aoki S, Taki T, Tobiume M, Zennami K, Katsuda R, Hirano M, Hayashida K, Mizumukai E, Nanaura H, Honda N. Yamada Y, et al. Among authors: tobiume m. Oncol Rep. 2007 Nov;18(5):1183-7. Oncol Rep. 2007. PMID: 17914570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters